Different studies have shown conflicting results about the association of ELAC2 variants and prostate cancer risk, suggested to be due to differences in ethnicity of individuals as well as environmental and lifestyle factors (Camp & Tavtigian, 2002; Studeny et al, 2002; Severi et al, 2003; Xu et al, 2010; Djomkam et al, 2020). Here, ELAC2 is linked to prostate cancer.